DiaMedica Therapeutics

DMACNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$363.713 M

$6.75 -0.29%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$32.8M

Loss-making

Shares outstanding

53,882,506

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#225Rocket PharmaceuticalsRCKT$394.2M
#226Prelude TherapeuticsPRLD$390.3M
#227DiaMedica TherapeuticsDMAC$363.7M
#228Lyell ImmunopharmaLYEL$360.5M
#229Foghorn TherapeuticsFHTX$356.4M

Where these numbers come from

Share counts and financials for DiaMedica Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.